ARTICLE | Company News
Ligand, Pfizer sales and marketing update
October 25, 2010 7:00 AM UTC
Pfizer launched Viviant bazedoxifene in Japan to treat postmenopausal osteoporosis. The selective estrogen receptor modulator (SERM) is marketed as Conbriza in Spain, where Almirall S.A. (Madrid:AL...